-
A prescription pill to treat postpartum depression hit the market in December, but most insurers do not yet have a policy on how patients can access it or when they will pay for it.
-
Bayer is adding two of its name-brand drugs to the roster of Cost Plus Drugs: the birth control pill Yaz and the menopause treatment Climara.
-
The Senate HELP committee questioned pharmaceutical CEOs about how much more Americans pay for the same drugs sold for less in Canada, Japan and Europe.
-
Bureaucratic hurdles mean just one-in-five people with opioid addiction get access to medication that could help them. The White House says new rules will help.
-
ODMHSAS is launching a new initiative to educate how to safely use, store and dispose of opioids and other prescription meds.
-
The Food and Drug Administration's authorization of Florida's plan to import prescription medicines from Canada is a first. But the state still has hurdles to clear before imports could begin.
-
The Oklahoma Opioid Abatement Board has received over 250 letters from local groups for $23 million in grants meant to counteract the impacts of the opioid epidemic.
-
Oklahoma Attorney General Gentner Drummond has extended the deadline for local entities to send letters of intent for grants meant to counteract impacts from the opioid epidemic.
-
The share of overdose deaths involving counterfeit pills doubled between 2019 and 2021, according to the CDC. Victims were often younger, Hispanic and had misused prescription drugs in the past.
-
The government will negotiate new prices for the commonly prescribed drugs, but the cuts won't take effect until 2026. In the meantime, drugmakers are fighting the negotiations with lawsuits.